Global 3D printed drugs Market Outlook Report 2017-2025
Posted by Bharat Book on April 4th, 2018
Bharat Book Bureau Provides the Trending Market Research Report on Global 3D printed drugs Market Size Study, By Drug (Spritam and Others) and Regional (US and Rest of the World) Forecasts, 2017-202 under Life Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects.
Global 3D Printed Drugs Industry valued approximately USD XX Million in 2016 is anticipated to grow with a healthy growth rate of XX% over the forecast period 2017-2025. 3D printed drugs are created by 3D printing technology which are used to treat patients who suffering from dysphagia. This medicine is easy to swallow and helpful for patients suffering from dysphagia. Increase in demand for fast soluble drugs which can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market. Furthermore, rising incidence of epilepsy cases, continues technological developments in 3D printing technique, and growing awareness for 3D printing technology in the developing countries are the major drivers of the market. However, concerns such as blueprint hacking and mislabeling of blueprint are going to hamper the market growth. Moreover, dicey regulatory scenario is another major restraint.
In 2016, Spritam is first 3D printed drug receive approval from the FDA. It is launched by Aprecia Pharmaceuticals. This medicine is currently active only in the U.S. region.
Request a free sample copy of 3D printed drugs Market Report @ https://www.bharatbook.com/request-sample/744312
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
-Rest of the World
Furthermore, years considered for the study are as follows:
-Historical year – 2015
-Base year – 2016
-Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the 3D printed drugs Market Study:
-Key Consulting Companies & Advisors
-Large, medium-sized, and small enterprises
-Value-Added Resellers (VARs)
-Third-party knowledge providers
Browse our full report with Table of Contents : http://www.bharatbook.com/drugs-market-research-reports-744312/global-3d-printed-drugs.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on : Twitter, Facebook, LinkedIn, Google Plus
Like it? Share it!
About the AuthorBharat Book
Joined: August 18th, 2017
Articles Posted: 3,022
More by this author